{"id":5147,"date":"2024-04-22T11:10:27","date_gmt":"2024-04-22T11:10:27","guid":{"rendered":"https:\/\/www.value-dx.eu\/?p=5147"},"modified":"2024-04-22T11:13:13","modified_gmt":"2024-04-22T11:13:13","slug":"value-dxs-closing-conference","status":"publish","type":"post","link":"https:\/\/www.value-dx.eu\/index.php\/2024\/04\/22\/value-dxs-closing-conference\/","title":{"rendered":"VALUE-Dx\u2019s Closing Conference"},"content":{"rendered":"\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-jzkylawd-ba86e75d702405f62001a756eb35483d\">\n.avia-section.av-jzkylawd-ba86e75d702405f62001a756eb35483d{\nbackground-color:#08b4a0;\nbackground-image:unset;\n}\n<\/style>\n<div id='av_section_1'  class='avia-section av-jzkylawd-ba86e75d702405f62001a756eb35483d main_color avia-section-default avia-no-border-styling  avia-builder-el-0  el_before_av_section  avia-builder-el-first  avia-bg-style-parallax container_wrap fullsize'  ><div class='container av-section-cont-open' ><main  role=\"main\" itemprop=\"mainContentOfPage\"  class='template-page content  av-content-full alpha units'><div class='post-entry post-entry-type-page post-entry-5147'><div class='entry-content-wrapper clearfix'>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-kx4q0z2f-61cac246230b2a5cf002700d011216ea\">\n#top .av-special-heading.av-kx4q0z2f-61cac246230b2a5cf002700d011216ea{\npadding-bottom:10px;\n}\nbody .av-special-heading.av-kx4q0z2f-61cac246230b2a5cf002700d011216ea .av-special-heading-tag .heading-char{\nfont-size:25px;\n}\n.av-special-heading.av-kx4q0z2f-61cac246230b2a5cf002700d011216ea .av-subheading{\nfont-size:15px;\n}\n<\/style>\n<div  class='av-special-heading av-kx4q0z2f-61cac246230b2a5cf002700d011216ea av-special-heading-h3 blockquote modern-quote modern-centered  avia-builder-el-1  el_before_av_codeblock  avia-builder-el-first  av-linked-heading'><h3 class='av-special-heading-tag '  itemprop=\"headline\"  >VALUE-Dx\u2019s Closing Conference<\/h3><div class=\"special-heading-border\"><div class=\"special-heading-inner-border\"><\/div><\/div><\/div>\n\n\n<\/div><\/div><\/main><!-- close content main element --><\/div><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-1cjng-9db903d36b325f87b66fb9ba7e96614e\">\n.avia-section.av-1cjng-9db903d36b325f87b66fb9ba7e96614e{\nbackground-color:#1b7ca4;\nbackground-image:unset;\n}\n<\/style>\n<div id='av_section_2'  class='avia-section av-1cjng-9db903d36b325f87b66fb9ba7e96614e main_color avia-section-default avia-no-border-styling  avia-builder-el-3  el_after_av_section  el_before_av_section  avia-bg-style-scroll container_wrap fullsize'  ><div class='container av-section-cont-open' ><div class='template-page content  av-content-full alpha units'><div class='post-entry post-entry-type-page post-entry-5147'><div class='entry-content-wrapper clearfix'>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-k0i4yzrj-318dd765ad6f41d2fe86b741f8548ed0\">\n.flex_column.av-k0i4yzrj-318dd765ad6f41d2fe86b741f8548ed0{\nborder-radius:0px 0px 0px 0px;\npadding:50px 5% 50px 5%;\n}\n<\/style>\n<div  class='flex_column av-k0i4yzrj-318dd765ad6f41d2fe86b741f8548ed0 av_one_full  avia-builder-el-4  el_before_av_one_fifth  avia-builder-el-first  first flex_column_div  '     ><section  class='av_textblock_section av-yfjs-bdca154287e84706a717077d4cd17983 '   itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock'  itemprop=\"text\" ><p><img fetchpriority=\"high\" decoding=\"async\" class=\"size-medium wp-image-5163 alignright\" src=\"https:\/\/www.value-dx.eu\/wp-content\/uploads\/2024\/04\/closing-conference_compressed-300x170.png\" alt=\"\" width=\"300\" height=\"170\" srcset=\"https:\/\/www.value-dx.eu\/wp-content\/uploads\/2024\/04\/closing-conference_compressed-300x170.png 300w, https:\/\/www.value-dx.eu\/wp-content\/uploads\/2024\/04\/closing-conference_compressed-768x435.png 768w, https:\/\/www.value-dx.eu\/wp-content\/uploads\/2024\/04\/closing-conference_compressed-705x400.png 705w, https:\/\/www.value-dx.eu\/wp-content\/uploads\/2024\/04\/closing-conference_compressed.png 1000w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/>VALUE-Dx officially ends on 30 September 2024, but until that time, project partners will continue to go to all lengths to generate ground-breaking and much needed insights into the value of diagnostics to improve antimicrobial prescription. These findings will be presented in a two-day Closing Conference in Valencia on 4 and 5 September 2024.<\/p>\n<p>The outcomes of VALUE-Dx will be of particular interest for a wide range of stakeholders, including policy makers, public health officials, regulators and patient organisations. VALUE-Dx partners are therefore developing a tailored conference programme to translate the major study results in recommendations, concrete conclusions and food for thought. To stimulate interaction and dialogue, the conference will offer a balanced mixture of lectures and panel discussions. The programme will be finalized in the weeks to come, but here are already some of the highlights:<\/p>\n<ol>\n<li>Main findings and implications for practice, policy and research of the PRUDENCE and ADEQUATE studies<\/li>\n<li>Health economics analysis and implications of the clinical trials<\/li>\n<li>Policy recommendations related to funding, pricing, and procurement to enhance the use of Point-of-Care Tests for CA-LRTI<\/li>\n<li>Reflections and insights into the possible exploitation of the study results<\/li>\n<li>Recommendations of VALUE-Dx on the role of rapid diagnostic tests for CA-LRTI<\/li>\n<li>Panel discussion on the User Requirement Specifications and the Technical Roadmap<\/li>\n<li>Interoperability of AMR data using OMOP: a Proof-of-Concept<\/li>\n<li>VALUE-Dx\u2019s clinical algorithm for community-acquired LRTI and the way forward<\/li>\n<\/ol>\n<p>The conference will end with an open panel discussion on the role of rapid diagnostics for CA-LRTI.<\/p>\n<p>On-site participation in the meeting will be limited to invited delegates, but the good news is that all sessions will be livestreamed and videorecorded. A detailed programme and registration details for the livestream will be available soon. Send an email to VALUE-Dx\u2019s project manager at <a href=\"mailto:david.depooter@uantwerpen.be\">david.depooter@uantwerpen.be<\/a> if you wish to be kept in the loop.<\/p>\n<\/div><\/section><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-3b8mw-b506a38e8d00a7f4906eea669cebc6be\">\n.flex_column.av-3b8mw-b506a38e8d00a7f4906eea669cebc6be{\nborder-radius:0px 0px 0px 0px;\npadding:0px 0px 0px 0px;\n}\n<\/style>\n<div  class='flex_column av-3b8mw-b506a38e8d00a7f4906eea669cebc6be av_one_fifth  avia-builder-el-6  el_after_av_one_full  el_before_av_one_fifth  first flex_column_div av-zero-column-padding  column-top-margin'     ><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-2lzlw-3d25ff9ce16d4f57844d3b5b4e0627c5\">\n.flex_column.av-2lzlw-3d25ff9ce16d4f57844d3b5b4e0627c5{\nborder-radius:0px 0px 0px 0px;\npadding:0px 0px 0px 0px;\n}\n<\/style>\n<div  class='flex_column av-2lzlw-3d25ff9ce16d4f57844d3b5b4e0627c5 av_one_fifth  avia-builder-el-7  el_after_av_one_fifth  el_before_av_one_fifth  flex_column_div av-zero-column-padding  column-top-margin'     ><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-7tlo-f8416bb2afc61a4a130355b19410e269\">\n.flex_column.av-7tlo-f8416bb2afc61a4a130355b19410e269{\nborder-radius:0px 0px 0px 0px;\npadding:0px 0px 0px 0px;\n}\n<\/style>\n<div  class='flex_column av-7tlo-f8416bb2afc61a4a130355b19410e269 av_one_fifth  avia-builder-el-8  el_after_av_one_fifth  el_before_av_one_fifth  flex_column_div av-zero-column-padding  column-top-margin'     ><div  class='av-social-sharing-box av-k0i4kjks-6d3450111d8e25130dca06d4190760bd av-social-sharing-box-minimal  avia-builder-el-9  avia-builder-el-no-sibling  av-social-sharing-box-fullwidth'><div class=\"av-share-box\"><ul class=\"av-share-box-list noLightbox\"><li class='av-share-link av-social-link-twitter avia_social_iconfont' ><a target=\"_blank\" aria-label=\"Share on X\" href='https:\/\/twitter.com\/share?text=VALUE-Dx%E2%80%99s%20Closing%20Conference&#038;url=https:\/\/www.value-dx.eu\/?p=5147' data-av_icon='\ue932' data-av_iconfont='entypo-fontello'  title='' data-avia-related-tooltip='Share on X'><span class='avia_hidden_link_text'>Share on X<\/span><\/a><\/li><li class='av-share-link av-social-link-linkedin avia_social_iconfont' ><a target=\"_blank\" aria-label=\"Share on LinkedIn\" href='https:\/\/linkedin.com\/shareArticle?mini=true&#038;title=VALUE-Dx%E2%80%99s%20Closing%20Conference&#038;url=https:\/\/www.value-dx.eu\/index.php\/2024\/04\/22\/value-dxs-closing-conference\/' data-av_icon='\ue8fc' data-av_iconfont='entypo-fontello'  title='' data-avia-related-tooltip='Share on LinkedIn'><span class='avia_hidden_link_text'>Share on LinkedIn<\/span><\/a><\/li><li class='av-share-link av-social-link-mail avia_social_iconfont' ><a  aria-label=\"Share by Mail\" href='mailto:?subject=VALUE-Dx%E2%80%99s%20Closing%20Conference&#038;body=https:\/\/www.value-dx.eu\/index.php\/2024\/04\/22\/value-dxs-closing-conference\/' data-av_icon='\ue805' data-av_iconfont='entypo-fontello'  title='' data-avia-related-tooltip='Share by Mail'><span class='avia_hidden_link_text'>Share by Mail<\/span><\/a><\/li><\/ul><\/div><\/div><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-1gk3g-e035d72a73a93486e640208771f4a074\">\n.flex_column.av-1gk3g-e035d72a73a93486e640208771f4a074{\nborder-radius:0px 0px 0px 0px;\npadding:0px 0px 0px 0px;\n}\n<\/style>\n<div  class='flex_column av-1gk3g-e035d72a73a93486e640208771f4a074 av_one_fifth  avia-builder-el-10  el_after_av_one_fifth  el_before_av_one_fifth  flex_column_div av-zero-column-padding  column-top-margin'     ><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-yzdo-63e3a9df4e270ed0fd52b6929706fb26\">\n.flex_column.av-yzdo-63e3a9df4e270ed0fd52b6929706fb26{\nborder-radius:0px 0px 0px 0px;\npadding:0px 0px 0px 0px;\n}\n<\/style>\n<div  class='flex_column av-yzdo-63e3a9df4e270ed0fd52b6929706fb26 av_one_fifth  avia-builder-el-11  el_after_av_one_fifth  avia-builder-el-last  flex_column_div av-zero-column-padding  column-top-margin'     ><\/div><\/div><\/div><\/div><!-- close content main div --><\/div><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-k0i590fy-427634ed8909a6d2106239c938ad0962\">\n.avia-section.av-k0i590fy-427634ed8909a6d2106239c938ad0962{\nbackground-color:#1b7ca4;\nbackground-image:unset;\n}\n<\/style>\n<div id='av_section_3'  class='avia-section av-k0i590fy-427634ed8909a6d2106239c938ad0962 main_color avia-section-default avia-no-border-styling  avia-builder-el-12  el_after_av_section  avia-builder-el-last  avia-bg-style-scroll container_wrap fullsize'  ><div class='container av-section-cont-open' ><div class='template-page content  av-content-full alpha units'><div class='post-entry post-entry-type-page post-entry-5147'><div class='entry-content-wrapper clearfix'>\n\n<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":152,"featured_media":5159,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-5147","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>VALUE-Dx\u2019s Closing Conference - value-dx<\/title>\n<meta name=\"description\" content=\"Antibiotic resistance is a growing concern. The PRUDENCE and ADEQUATE trials therefore aim to assess the impact of reducing antibiotic prescriptions on the emergence of resistant antimicrobials.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.value-dx.eu\/index.php\/2024\/04\/22\/value-dxs-closing-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VALUE-Dx\u2019s Closing Conference - value-dx\" \/>\n<meta property=\"og:description\" content=\"Antibiotic resistance is a growing concern. The PRUDENCE and ADEQUATE trials therefore aim to assess the impact of reducing antibiotic prescriptions on the emergence of resistant antimicrobials.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.value-dx.eu\/index.php\/2024\/04\/22\/value-dxs-closing-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"value-dx\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-22T11:10:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-22T11:13:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.value-dx.eu\/wp-content\/uploads\/2024\/04\/closing-conference.png\" \/>\n\t<meta property=\"og:image:width\" content=\"10492\" \/>\n\t<meta property=\"og:image:height\" content=\"5946\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Leandra\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ValueDx\" \/>\n<meta name=\"twitter:site\" content=\"@ValueDx\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Leandra\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2024\\\/04\\\/22\\\/value-dxs-closing-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2024\\\/04\\\/22\\\/value-dxs-closing-conference\\\/\"},\"author\":{\"name\":\"Leandra\",\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/#\\\/schema\\\/person\\\/9da693a7844518fa62482abe916eba8d\"},\"headline\":\"VALUE-Dx\u2019s Closing Conference\",\"datePublished\":\"2024-04-22T11:10:27+00:00\",\"dateModified\":\"2024-04-22T11:13:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2024\\\/04\\\/22\\\/value-dxs-closing-conference\\\/\"},\"wordCount\":1382,\"image\":{\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2024\\\/04\\\/22\\\/value-dxs-closing-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.value-dx.eu\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/closing-conference.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2024\\\/04\\\/22\\\/value-dxs-closing-conference\\\/\",\"url\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2024\\\/04\\\/22\\\/value-dxs-closing-conference\\\/\",\"name\":\"VALUE-Dx\u2019s Closing Conference - value-dx\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2024\\\/04\\\/22\\\/value-dxs-closing-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2024\\\/04\\\/22\\\/value-dxs-closing-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.value-dx.eu\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/closing-conference.png\",\"datePublished\":\"2024-04-22T11:10:27+00:00\",\"dateModified\":\"2024-04-22T11:13:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/#\\\/schema\\\/person\\\/9da693a7844518fa62482abe916eba8d\"},\"description\":\"Antibiotic resistance is a growing concern. The PRUDENCE and ADEQUATE trials therefore aim to assess the impact of reducing antibiotic prescriptions on the emergence of resistant antimicrobials.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2024\\\/04\\\/22\\\/value-dxs-closing-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2024\\\/04\\\/22\\\/value-dxs-closing-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2024\\\/04\\\/22\\\/value-dxs-closing-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.value-dx.eu\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/closing-conference.png\",\"contentUrl\":\"https:\\\/\\\/www.value-dx.eu\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/closing-conference.png\",\"width\":10492,\"height\":5946},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2024\\\/04\\\/22\\\/value-dxs-closing-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/homepage\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VALUE-Dx\u2019s Closing Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/#website\",\"url\":\"https:\\\/\\\/www.value-dx.eu\\\/\",\"name\":\"value-dx\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.value-dx.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/#\\\/schema\\\/person\\\/9da693a7844518fa62482abe916eba8d\",\"name\":\"Leandra\",\"url\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/author\\\/leandra\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VALUE-Dx\u2019s Closing Conference - value-dx","description":"Antibiotic resistance is a growing concern. The PRUDENCE and ADEQUATE trials therefore aim to assess the impact of reducing antibiotic prescriptions on the emergence of resistant antimicrobials.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.value-dx.eu\/index.php\/2024\/04\/22\/value-dxs-closing-conference\/","og_locale":"en_US","og_type":"article","og_title":"VALUE-Dx\u2019s Closing Conference - value-dx","og_description":"Antibiotic resistance is a growing concern. The PRUDENCE and ADEQUATE trials therefore aim to assess the impact of reducing antibiotic prescriptions on the emergence of resistant antimicrobials.","og_url":"https:\/\/www.value-dx.eu\/index.php\/2024\/04\/22\/value-dxs-closing-conference\/","og_site_name":"value-dx","article_published_time":"2024-04-22T11:10:27+00:00","article_modified_time":"2024-04-22T11:13:13+00:00","og_image":[{"width":10492,"height":5946,"url":"https:\/\/www.value-dx.eu\/wp-content\/uploads\/2024\/04\/closing-conference.png","type":"image\/png"}],"author":"Leandra","twitter_card":"summary_large_image","twitter_creator":"@ValueDx","twitter_site":"@ValueDx","twitter_misc":{"Written by":"Leandra","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.value-dx.eu\/index.php\/2024\/04\/22\/value-dxs-closing-conference\/#article","isPartOf":{"@id":"https:\/\/www.value-dx.eu\/index.php\/2024\/04\/22\/value-dxs-closing-conference\/"},"author":{"name":"Leandra","@id":"https:\/\/www.value-dx.eu\/#\/schema\/person\/9da693a7844518fa62482abe916eba8d"},"headline":"VALUE-Dx\u2019s Closing Conference","datePublished":"2024-04-22T11:10:27+00:00","dateModified":"2024-04-22T11:13:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.value-dx.eu\/index.php\/2024\/04\/22\/value-dxs-closing-conference\/"},"wordCount":1382,"image":{"@id":"https:\/\/www.value-dx.eu\/index.php\/2024\/04\/22\/value-dxs-closing-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.value-dx.eu\/wp-content\/uploads\/2024\/04\/closing-conference.png","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.value-dx.eu\/index.php\/2024\/04\/22\/value-dxs-closing-conference\/","url":"https:\/\/www.value-dx.eu\/index.php\/2024\/04\/22\/value-dxs-closing-conference\/","name":"VALUE-Dx\u2019s Closing Conference - value-dx","isPartOf":{"@id":"https:\/\/www.value-dx.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.value-dx.eu\/index.php\/2024\/04\/22\/value-dxs-closing-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.value-dx.eu\/index.php\/2024\/04\/22\/value-dxs-closing-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.value-dx.eu\/wp-content\/uploads\/2024\/04\/closing-conference.png","datePublished":"2024-04-22T11:10:27+00:00","dateModified":"2024-04-22T11:13:13+00:00","author":{"@id":"https:\/\/www.value-dx.eu\/#\/schema\/person\/9da693a7844518fa62482abe916eba8d"},"description":"Antibiotic resistance is a growing concern. The PRUDENCE and ADEQUATE trials therefore aim to assess the impact of reducing antibiotic prescriptions on the emergence of resistant antimicrobials.","breadcrumb":{"@id":"https:\/\/www.value-dx.eu\/index.php\/2024\/04\/22\/value-dxs-closing-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.value-dx.eu\/index.php\/2024\/04\/22\/value-dxs-closing-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.value-dx.eu\/index.php\/2024\/04\/22\/value-dxs-closing-conference\/#primaryimage","url":"https:\/\/www.value-dx.eu\/wp-content\/uploads\/2024\/04\/closing-conference.png","contentUrl":"https:\/\/www.value-dx.eu\/wp-content\/uploads\/2024\/04\/closing-conference.png","width":10492,"height":5946},{"@type":"BreadcrumbList","@id":"https:\/\/www.value-dx.eu\/index.php\/2024\/04\/22\/value-dxs-closing-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.value-dx.eu\/index.php\/homepage\/"},{"@type":"ListItem","position":2,"name":"VALUE-Dx\u2019s Closing Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.value-dx.eu\/#website","url":"https:\/\/www.value-dx.eu\/","name":"value-dx","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.value-dx.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.value-dx.eu\/#\/schema\/person\/9da693a7844518fa62482abe916eba8d","name":"Leandra","url":"https:\/\/www.value-dx.eu\/index.php\/author\/leandra\/"}]}},"jetpack_featured_media_url":"https:\/\/www.value-dx.eu\/wp-content\/uploads\/2024\/04\/closing-conference.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/posts\/5147","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/users\/152"}],"replies":[{"embeddable":true,"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/comments?post=5147"}],"version-history":[{"count":0,"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/posts\/5147\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/media\/5159"}],"wp:attachment":[{"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/media?parent=5147"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/categories?post=5147"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/tags?post=5147"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}